APAC Region Distribution Considerations for Clinical Trial Supplies
Summary: The Asia-Pacific (APAC) region has become an emerging market for pharmaceutical and biotech innovation, including clinical studies. Managing a clinical supply distribution strategy within APAC can be very complex, due to differences in regulations between countries, as well as significant changes in weather and climate across the region as a whole. Maintaining business continuity when executing a supply chain plan is critical to a trial’s success. Catalent’s Daniel Gao and Tracey Clare address common distribution challenges encountered within APAC, and discuss possible solutions a sponsor should consider and implement.